Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

view more →

AtaCor Medical is developing a novel extracardiac pacing system that does not require leads or hardware to be placed inside or onto the heart.

view more →

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

view more →

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

view more →

Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI

view more →

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into one single catheter.

view more →

CVRx has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. IPO in June 2021 (NASDAQ: CVRX).

view more →

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

view more →

Developer of a system to enhance embolic cerebral protection. Acquired by Edwards Lifesciences (NYSE: EW) in March 2011.

view more →

Endogenex is a clinical stage company, founded to improve outcomes for people living with Type 2 Diabetes.

view more →

Developer of biologic and medical device technologies for wound management designed to improve the safety and availability of human blood supply.

view more →

GoCheck Kids is the leading digital vision screening platform for children. 

view more →

Provider of a histotripsy platform designed for the treatment of cancer. Acquired by Bezos Expeditions, Wellington K5 Global 2025

view more →

iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke.

view more →

Software and logistics solution for physicians allowing them to become independent DME suppliers

view more →

SafeRide’s technology provides end-to-end data transparency while improving patient experience, population health, and program efficiency.

view more →

Standard Bariatrics is developing a clamp and stapler to standardize sleeve gastrectomy procedures. Acquired by Teleflex in September 2022.

view more →

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

view more →

Sleep management platform built to address sleep conditions from testing through ongoing care via a wearable patch